Clinical efficacy of sertraline alone and augmented with gabapentin in recently abstinent cocaine-dependent patients with depressive symptoms

Journal of Clinical Psychopharmacology

Volumn 34, Issue 2, 2014, Pages 234-239

  Mancino, Michael J ^a   McGaugh, Janette ^a   Chopra, Mohit P ^b   Guise, Joseph B ^a   Cargile, Christopher ^a   Williams, D Keith ^a   Thostenson, Jeff ^a   Kosten, Thomas R ^c   Sanders, Nichole ^a   Oliveto, Alison ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Cocaine dependence; Cognitive behavioral therapy; Gabapentin; Placebo control; Randomized clinical trial; Relapse prevention; Sertraline

Indexed keywords

GABAPENTIN; PLACEBO; SERTRALINE;

ALLERGIC REACTION; ARTICLE; BRUXISM; COCAINE DEPENDENCE; COGNITIVE THERAPY; CONTROLLED STUDY; DEPRESSION; DIARRHEA; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG EFFICACY; FEMALE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; NAUSEA; OUTPATIENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELAPSE; RESIDENTIAL CARE; SELF REPORT; SEXUAL DYSFUNCTION; TREATMENT OUTCOME; TREMOR; URINALYSIS; VOMITING;

ADULT; AMINES; COCAINE-RELATED DISORDERS; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; CYCLOHEXANECARBOXYLIC ACIDS; DEPRESSION; DIAGNOSIS, DUAL (PSYCHIATRY); DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; GABA AGONISTS; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; MEDICATION ADHERENCE; PATIENT COMPLIANCE; RECURRENCE; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; YOUNG ADULT;

EID: 84896390507     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0000000000000062     Document Type: Article

References (39)

1. Maraj S, Figueredo VM, Lynn Morris D. Cocaine and the heart. Clin Cardiol. 2010;33(5): 264-269.
2. US. Department of Health and Human Services. Mental Health: A Report of the Surgeon General-Executive Summary. Rockville, MD: Substance Abuse and Mental Health Services, NIH, NIMH; 1999.
3. Sorenson JL, Wermuth LA, Gibson DR, et al. Preventing AIDS in Drug Abusers and Their Sexual Partners. New York, NY: Guilford; 1991.
4. Wild TC, el-Guebaly N, Fischer B, et al. Comorbid depression among untreated illicit opiate users: results from a multisite Canadian study. Can J Psychiatry. 2005;50(9): 512-518.
5. Conner KR, Pinquart M, Holbrook AP. Meta-analysis of depression and substance use and impairment among cocaine users. Drug Alcohol Depend. 2008;98(1-2): 13-23.
6. McKay JR, Pettinati HM, Morrison R, et al. Relation of depression diagnoses to 2-year outcomes in cocaine-dependent patients in a randomized continuing care study. Psychol Addict Behav. 2002;16(3): 225-235.
7. Batki SL, Washburn AM, Delucchi K, et al. A controlled trial of fluoxetine in crack cocaine dependence. Drug Alcohol Depend. 1996;41(2): 137-142.
8. Oliveto A, Poling J, Mancino MJ, et al. Sertraline delays relapse in recently abstinent cocaine-dependent patients with depressive symptoms. Addiction. 2012;107(1): 131-141. PMCID: PMC3237722.
9. Moeller FG, Schmitz JM, Steinberg JL, et al. Citalopram combined with behavioral therapy reduces cocaine use: a double-blind, placebo-controlled trial. Am J Drug Alcohol Abuse. 2007; 33(3): 367-378.
10. Schmitz JM, Averill P, Stotts AL, et al. Fluoxetine treatment of cocaine-dependent patients with major depressive disorder. Drug Alcohol Depend. 2001;63(3): 207-214.
11. Volkow ND, Fowler JS, Wolf AP, et al. Effects of chronic cocaine abuse on postsynaptic dopamine receptors. Am J Psychiatry. 1990;147(6): 719-724.
12. Rossetti ZL, Melis F, Carboni S, et al. Dramatic depletion of mesolimbic extracellular dopamine after withdrawal from morphine, alcohol or cocaine: a common neurochemical substrate for drug dependence. Ann N Y Acad Sci. 1992;654: 513-516.
13. Jimerson DC. Role of dopamine mechanisms in the affective disorders. In: Meltzer HY, ed. Psychopharmacology: The Third Generation of Progress. New York, NY: Raven Press; 1987: 505-511.
14. Simpson DD, Joe GW, Broome KM. A national 5-year follow-up of treatment outcomes for cocaine dependence. Arch Gen Psychiatry. 2002;59(6): 538-544.
15. Sanacora G, Mason GF, Krystal JH. Impairment of GABAergic transmission in depression: new insights from neuroimaging studies. Crit Rev Neurobiol. 2000;14(1): 23-45.
16. Volkow ND, Wang GJ, Fowler JS, et al. Enhanced sensitivity to benzodiazepines in active cocaine-abusing subjects: a PET study. Am J Psychiatry. 1998;155(2): 200-206.
17. McAllister K, Goeders N, Dworkin S. Chronic cocaine modifies brain benzodiazepine receptor densities. NIDA Res Monog. 1988;81: 101-108.
18. Smith WT, Londborg PD, Glaudin V, et al. Is extended clonazepam cotherapy of fluoxetine effective for outpatients with major depression? J Affect Disord. 2002;70(3): 251-259.
19. Koe BK, Weissman A, Welch WM, et al. Sertraline, 1S,4S-N-methyl-4- (3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthylamine, a new uptake inhibitor with selectivity for serotonin. J Pharmacol Exp Ther. 1983;226(3): 686-700.
20. Sokolski KN, Green C, Maris DE, et al. Gabapentin as an adjunct to standard mood stabilizers in outpatients with mixed bipolar symptomatology. Ann Clin Psychiatry. 1999;11(4): 217-222.
21. Wei LJ, Lachin JM. Properties of the urn randomization in clinical trials. Control Clin Trials. 1988;9(4): 345-364.
22. Carroll KM. A Cognitive-Behavioral Approach: Treating Cocaine Addiction. Rockville, MD: National Institute on Drug Abuse, 1998.
23. Preskorn SH, Lane RM. Sertraline 50 mg daily: the optimal dose in the treatment of depression. Int Clin Psychopharmacol. 1995;10(3): 129-141.
24. Bisaga A, Aharonovich E, Garawi F, et al. A randomized placebo-controlled trial of gabapentin for cocaine dependence. Drug Alcohol Depend. 2006;81(3): 267-274.
25. Gonzalez G, Desai R, Sofuoglu M, et al. Clinical efficacy of gabapentin versus tiagabine for reducing cocaine use among cocaine-dependent methadone-treated patients. Drug Alcohol Depend. 2007;87(1): 1-9.
26. Hart CL, Haney M, Vosburg SK, et al. Gabapentin does not reduce smoked cocaine self-administration: employment of a novel self-administration procedure. Behav Pharmacol. 2007;18(1): 71-75.
27. First MB, Spitzer RL, Gibbon M, et al. User's Guide for the Structured Clinical Interview for DSM-IV Personality Disorders (SCID-II). Washington, DC: American Psychiatric Press; 1995.
28. McLellan AT, Luborsky L, Woody GE, et al. An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. J Nerv Ment Dis. 1980;168(1): 26-33.
29. Hamilton MA. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23: 56-82.
30. Kosten T, Oliveto A, Feingold A, et al. Desipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained patients. Drug Alcohol Depend. 2003;70: 315-325.
31. Winstanley EL, Bigelow GE, Silverman K, et al. A randomized controlled trial of fluoxetine in the treatment of cocaine dependence among methadone-maintained patients. J Subst Abuse Treat. 2011;40(3): 255-264.
32. Schmitz JM, Rhoades HM, Elk R, et al. Medication take-home doses and contingency management. Exp Clin Psychopharmacol. 1998;6(2): 162-168.
33. Pollack MH, Rosenbaum JF. Fluoxetine treatment of cocaine abuse in heroin addicts. J Clin Psychiatry. 1991;52(1): 31-33.
34. Carrasco JL, Sandner C. Clinical effects of pharmacological variations in selective serotonin reuptake inhibitors: an overview. Int J Clin Pract. 2005;59(12): 1428-1434.
35. Buchman N, Strous RD, Baruch Y. Side effects of long-term treatment with fluoxetine. Clin Neuropharmacol. 2002;25(1): 55-57.
36. Shorter D, Kosten TR. Novel pharmacotherapeutic treatments for cocaine addiction. BMC Med. 2011;9: 119.
37. McDowell D, Nunes EV, Seracini AM, et al. Desipramine treatment of cocaine-dependent patients with depression: a placebo-controlled trial. Drug Alcohol Depend. 2005;80(2): 209-221.
38. Higgins ST, Heil SH, Dantona R, et al. Effects of varying the monetary value of voucher-based incentives on abstinence achieved during and following treatment among cocaine-dependent outpatients. Addiction. 2007;102(2): 271-281.
39. Vayalapalli S, Vaughn M, Salles-Shahid K, et al. High-dose citalopram for cocaine dependence in veteran populationVa pilot project. Am J Addict. 2011;20(5): 485-486.